Skin surface temperature rhythms as potential circadian biomarkers for personalized chronotherapeutics in cancer patients

Interface Focus

Volumn 1, Issue 1, 2011, Pages 48-60

  Scully, Christopher G ^a,b   Karaboué, Abdoulaye ^c,d   Liu, Wei Min ^a   Meyer, Joseph ^a   Innominato, Pasquale F ^c,d,e   Chon, Ki H ^b   Gorbach, Alexander M ^a   Lévi, Francis ^c,d,e  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^b Worcester Polytechnic Institute   (United States)

^c INSERM   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e HÔPITAL PAUL BROUSSE   (France)

Author keywords

Biomarker; Body temperature; Cancer; Chronotherapeutics; Circadian rhythm; Personalized medicine

Indexed keywords

EID: 81855188821     PISSN: 20428898     EISSN: 20428901     Source Type: Journal    
DOI: 10.1098/rsfs.2010.0012     Document Type: Article

References (44)

1. Panda, S., Hogenesch, J. B. & Kay, S. A. 2002 Circadian rhythms from flies to human. Nature 417, 329-335. (doi:10.1038/417329a)
2. Reppert, S. M. & Weaver, D. R. 2002 Coordination of circadian timing in mammals. Nature 418, 935-941. (doi:10.1038/nature00965)
3. Ashall, L. et al. 2009 Pulsatile stimulation determines timing and specificity of NF-κB-dependent transcription. Science 324, 242-246. (doi:10.1126/science.1164860)
4. Dibner, C., Schibler, U. & Albrecht, U. 2010 The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu. Rev. Physiol. 72, 517-549. (doi:10.1146/annurev-physiol-021909-135821)
5. Lévi, F., Okyar, A., Dulong, S., Innominato, P. F. & Clairambault, J. 2010 Circadian timing in cancer treatments. Annu. Rev. Pharmacol. Toxicol. 50, 377-421. (doi:10.1146/annurev.pharmtox.48.113006.094626)
6. Takahashi, J. S., Hong, H.-K., Ko, C. H. & Mcdearmon, E. L. 2008 The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat. Rev. Genet. 9, 764-775. (doi:10.1038/nrg2430)
7. Lévi, F., Focan, C., Karaboué, A., De La Valette, V., Focan-Henrard, D., Baron, B., Kreutz, F. & Giacchetti, S. 2007 Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Adv. Drug Deliv. Rev. 59, 1015-1035. (doi:10.1016/j.addr.2006.11.001)
8. Altinok, A., Lévi, F. & Goldbeter, A. 2007 A cell cycle automaton model for probing circadian patterns of anticancer drug delivery. Adv. Drug Deliv. Rev. 59, 1036-1053. (doi:10.1016/j.addr.2006.09.022)
9. Altinok, A., Lévi, F. & Goldbeter, A. 2009 Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling. Eur. J. Pharm. Sci. 36, 20-38. (doi:10.1016/j.ejps.2008.10.024)
10. Bernard, S., Čajavec Bernard, B., Lévi, F. & Herzel, H. 2010 Tumor Growth rate determines the timing of optimal chronomodulated treatment schedules. PLoS Comput. Biol. 6, e1000712. (doi:10.1371/journal.pcbi.1000712)
11. Lévi, F., Altinok, A. & Goldbeter, A. 2010 Circadian rhythms and chronotherapeutics, ch. 15 (eds F. Marcus & A. Cesario). New York, NY: Springer Verlag.
12. Lévi, F., Zidani, R. & Misset, L. 1997 Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 350, 681-686. (doi:10.1016/S0140-6736(97)03358-8)
13. Giacchetti, S. et al. 2006 Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group. J. Clin. Oncol. 24, 3562-3569. (doi:10.1200/jco.2006.06.1440)
14. Giacchetti, S. et al. In preparation. Relevance of gender for optimal efficacy of chronomodulated versus conventional delivery of 5-fluorouracil-leucovorin and oxaliplatin as first line treatment for metastatic colorectal cancers in first meta-analysis of three international randomized trials using individual patient data.
15. Filipski, E., Innominato, P. F., Wu, M., Li, X.-M., Iacobelli, S., Xian, L.-J. & Lévi, F. 2005 Effects of light and food schedules on liver and tumor molecular clocks in mice. J. Natl Cancer Inst. 97, 507-517. (doi:10.1093/jnci/dji083)
16. Filipski, E., King, V. M., Li, X., Granda, T. G., Mormont, M.-C., Liu, X., Claustrat, B., Hastings, M. H. & Lévi, F. 2002 Host circadian clock as a control point in tumor progression. J. Natl Cancer Inst. 94, 690-697. (doi:10. 1093/jnci/94.9.690)
17. Lee, S., Donehower, L. A., Herron, A. J., Moore, D. D. & Fu, L. 2010 Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS ONE 5, e10995. (doi:10.1371/journal.pone.0010995)
18. Innominato, P. F. et al. 2009 Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 69, 4700-4707. (doi:10.1158/0008-5472.can-08-4747)
19. Mormont, M.-C. et al. 2000 Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin. Cancer Res. 6, 3038-3045.
20. Sephton, S. E., Sapolsky, R. M., Kraemer, H. C. & Spiegel, D. 2000 Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl Cancer Inst. 92, 994-1000. (doi:10.1093/jnci/92.12.994)
21. Iurisci, I., Filipski, E., Reinhardt, J., Bach, S., Gianella-Borradori, A., Iacobelli, S., Meijer, L. & Lévi, F. 2006 Improved tumor control through circadian clock induction by seliciclib, a cyclin-dependent kinase inhibitor. Cancer Res. 66, 10720-10728. (doi:10.1158/0008-5472.can-06-2086)
22. Li, X.-M., Delaunay, F., Dulong, S., Claustrat, B., Zampera, S., Fujii, Y., Teboul, M., Beau, J. & Lévi, F. 2010 Cancer inhibition through circadian reprogramming of tumor transcriptome with meal timing. Cancer Res. 70, 3351-3360. (doi:10.1158/0008-5472.can-09-4235)
23. Innominato, P. F., Mormont, M.-C., Rich, T. A., Waterhouse, J., Lévi, F. A. & Bjarnason, G. A. 2009 Circadian disruption, fatigue, and anorexia clustering in advanced cancer patients: implications for innovative therapeutic approaches. Integr. Cancer Ther. 8, 361-370. (doi:10.1177/1534735409355293)
24. Czeisler, C. A. et al. 1999 Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 284, 2177-2181. (doi:10.1126/science.284.5423.2177)
25. Klerman, E. B., Gershengorn, H. B., Duffy, J. F. & Kronauer, R. E. 2002 Comparisons of the variability of three markers of the human circadian pacemaker. J. Biol. Rhythm. 17, 181-193. (doi:10.1177/07487300212 9002474)
26. Moore-Ede, M. C., Czeisler, C. A. & Richardson, G. S. 1983 Circadian timekeeping in health and disease. New Engl. J. Med. 309, 469-476. (doi:10.1056/NEJM198308 253090806)
27. Brown, S. A., Zumbrunn, G., Fleury-Olela, F., Preitner, N. & Schibler, U. 2002 Rhythms of mammalian body temperature can sustain peripheral circadian clocks. Curr. Biol. 12, 1574-1583. (doi:10.1016/S0960-9822(02)01145-4)
28. Krauchi, K. & Deboer, T. 2010 The interrelationship between sleep regulation and thermoregulation. Front. Biosci. 15, 604-625. (doi:10.2741/3636)
29. Van Someren, E. J. W. 2006 Mechanisms and functions of coupling between sleep and temperature rhythms. Prog. Brain Res. 153, 309-324. (doi:10.1016/S0079-6123 (06)53018-3)
30. Gholam, D. et al. 2006 Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-fluorouracil as ambulatory salvage therapy in patients with irinotecanand oxaliplatin-resistant metastatic colorectal cancer. Oncologist 11, 1072-1080. (doi:10.1634/theoncologist. 11-10-1072)
31. Lévi, F. et al. 2010 Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability. Cancer Chemother. Pharmacol. 1-10. (doi:10.1007/s00280-010-1327-8)
32. Blackwell, T., Redline, S., Ancoli-Israel, S., Schneider, J. L., Surovec, S., Johnson, N. L., Cauley, J. A. & Stone, K. L. 2008 Comparison of sleep parameters from actigraphy and polysomnography in older women: the SOF study. Sleep 31, 283-291.
33. Jean-Louis, G., Kripke, D. F., Mason, W. J., Elliott, J. A. & Youngstedt, S. D. 2001 Sleep estimation from wrist movement quantified by different actigraphic modalities. J. Neurosci. Methods 105, 185-191. (doi:10.1016/S0165-0270(00)00364-2)
34. Frick, P., Baliunas, S. L., Galyagin, D., Sokoloff, D. & Soon, W. 1997 Wavelet analysis of stellar chromospheric activity variations. Astrophys. J. 483, 426. (doi:10.1086/304206)
35. Frick, P., Grossmann, A. & Tchamitchian, P. 1998 Wavelet analysis of signals with gaps. J. Math. Phys. 39, 4091-4107. (doi:10.10631/1.532485)
36. Tankanag, A. & Chemeris, N. 2008 Application of the adaptive wavelet transform for analysis of blood flow oscillations in the human skin. Phys. Med. Biol. 53, 5967. (doi:10.1088/0031-9155/53/21/005)
37. Dispersyn, G., Touitou, Y., Coste, O., Jouffroy, L., Lleu, J. C., Challet, E. & Pain, L. 2009 Desynchronization of daily rest-activity rhythm in the days following light propofol anesthesia for colonoscopy. Clin. Pharmacol. Ther. 85, 51-55. (doi:10.1038/clpt.2008.179)
38. Brown, S. A. et al. 2005 The period length of fibroblast circadian gene expression varies widely among human individuals. PLoS Biol. 3, e338. (doi:10.1371/journal. pbio.0030338)
39. Brown, S. A., Kunz, D., Dumas, A., Westermark, P. O., Vanselow, K., Tilmann-Wahnschaffe, A., Herzel, H. & Kramer, A. 2008 Molecular insights into human daily behavior. Proc. Natl Acad. Sci. USA 105, 1602-1607. (doi:10.1073/pnas.0707772105)
40. Hastings, M. H., Reddy, A. B. & Maywood, E. S. 2003 A clockwork web: circadian timing in brain and periphery, in health and disease. Nat. Rev. Neurosci. 4, 649-661. (doi:10.1038/nrn1177)
41. Stratmann, M. & Schibler, U. 2006 Properties, entrainment, and physiological functions of mammalian peripheral oscillators. J. Biol. Rhythm. 21, 494-506. (doi:10.1177/0748730406293889)
42. Zvonic, S. et al. 2006 Characterization of peripheral circadian clocks in adipose tissues. Diabetes 55, 962-970. (doi:10.2337/diabetes.55.04.06.db05-0873)
43. Van Someren, E. J. W. 2000 More than a marker: interaction between the circadian regulation of temperature and sleep, age-related changes, and treatment possibilities. Chronobiol. Int. J. Biol. Med. Rhythm Res. 17, 313-354. (doi:10.1081/CBI-100101050)
44. Innominato, P. F., Lévi, F. A. & Bjarnason, G. A. 2010 Chronotherapy and the molecular clock: clinical implications in oncology. Adv. Drug Deliv. Rev. 62, 979-1001. (doi:10.1016/j.addr.2010.06. 002)